Published in Cell Death Dis on January 17, 2013
Endocrine factors modulating immune responses in pregnancy. Front Immunol (2014) 0.94
Mast cell-mediated and associated disorders in pregnancy: a risky game with an uncertain outcome? Front Immunol (2014) 0.84
Control of uterine microenvironment by foxp3(+) cells facilitates embryo implantation. Front Immunol (2013) 0.84
Cellular Regulation of the Uterine Microenvironment That Enables Embryo Implantation. Front Immunol (2015) 0.82
Effects of heme oxygenase-1 on innate and adaptive immune responses promoting pregnancy success and allograft tolerance. Front Pharmacol (2015) 0.80
Mast cells as novel mediators of reproductive processes. Front Immunol (2013) 0.79
Immunogenetic contributions to recurrent pregnancy loss. J Assist Reprod Genet (2016) 0.79
Chymase-producing cells of the innate immune system are required for decidual vascular remodeling and fetal growth. Sci Rep (2017) 0.77
Transfer of regulatory T cells into abortion-prone mice promotes the expansion of uterine mast cells and normalizes early pregnancy angiogenesis. Sci Rep (2015) 0.76
Genomic analysis of the appearance of ovarian mast cells in neonatal MRL/MpJ mice. PLoS One (2014) 0.75
Safeguarding of Fetal Growth by Mast Cells and Natural Killer Cells: Deficiency of One Is Counterbalanced by the Other. Front Immunol (2017) 0.75
Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature (1992) 16.46
Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth. J Exp Med (1986) 9.86
BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator. Science (1999) 5.99
Molecular bases of dominant negative and loss of function mutations at the murine c-kit/white spotting locus: W37, Wv, W41 and W. EMBO J (1990) 5.08
Mast cells in the development of adaptive immune responses. Nat Immunol (2005) 4.96
Physiological consequences of loss of plasminogen activator gene function in mice. Nature (1994) 4.40
Mast cell-deficient W-sash c-kit mutant Kit W-sh/W-sh mice as a model for investigating mast cell biology in vivo. Am J Pathol (2005) 3.88
Expression and function of c-kit in hemopoietic progenitor cells. J Exp Med (1991) 3.48
Cre-mediated cell ablation contests mast cell contribution in models of antibody- and T cell-mediated autoimmunity. Immunity (2011) 2.87
Stimulation of fibroblast cell growth, matrix production, and granulation tissue formation by connective tissue growth factor. J Invest Dermatol (1996) 2.70
Mast cells are key promoters of contact allergy that mediate the adjuvant effects of haptens. Immunity (2011) 2.39
Tissue-selective mast cell reconstitution and differential lung gene expression in mast cell-deficient Kit(W-sh)/Kit(W-sh) sash mice. Clin Exp Allergy (2005) 2.32
Mast cells and basophils. Curr Opin Hematol (2000) 2.01
A new allele sash (Wsh) at the W-locus and a spontaneous recessive lethal in mice. Genet Res (1982) 1.97
Cytosolic phospholipase A2alpha is crucial [correction of A2alpha deficiency is crucial] for 'on-time' embryo implantation that directs subsequent development. Development (2002) 1.91
Mast cells and angiogenesis. APMIS (2002) 1.88
Regulation of proliferation and differentiation in spermatogonial stem cells: the role of c-kit and its ligand SCF. Development (2000) 1.88
Abnormal T-cell reactivity against paternal antigens in spontaneous abortion: adoptive transfer of pregnancy-induced CD4+CD25+ T regulatory cells prevents fetal rejection in a murine abortion model. Am J Pathol (2005) 1.74
Regulatory circuits mediated by lectin-glycan interactions in autoimmunity and cancer. Immunity (2012) 1.67
Asthma exacerbations during pregnancy: incidence and association with adverse pregnancy outcomes. Thorax (2006) 1.49
Mast cells--key effector cells in immune responses. Trends Immunol (2007) 1.48
The kit ligand encoded at the murine Steel locus: a pleiotropic growth and differentiation factor. Curr Opin Cell Biol (1991) 1.47
What have mast cells to do with edema formation, the consecutive repair and fibrinolysis? Int Arch Allergy Immunol (1998) 1.44
Murine transforming growth factor-beta 2 cDNA sequence and expression in adult tissues and embryos. Mol Endocrinol (1989) 1.40
The W(sh), W(57), and Ph Kit expression mutations define tissue-specific control elements located between -23 and -154 kb upstream of Kit. Blood (1999) 1.38
Mast cell-specific Cre/loxP-mediated recombination in vivo. Transgenic Res (2007) 1.36
Stem cell factor induces mast cell adhesion to fibronectin. J Immunol (1994) 1.28
Galectin fingerprinting in human endometrium and decidua during the menstrual cycle and in early gestation. Mol Hum Reprod (2005) 1.14
C-kit gene is expressed by skin mast cells in embryos but not in puppies of Wsh/Wsh mice: age-dependent abolishment of c-kit gene expression. Blood (1994) 1.12
Physical mapping of the Tec and Gabrb1 loci reveals that the Wsh mutation on mouse chromosome 5 is associated with an inversion. Hum Mol Genet (1995) 1.10
Analysis of uterine natural killer cells in mice. Methods Mol Biol (2010) 1.08
Estradiol and progesterone regulate the migration of mast cells from the periphery to the uterus and induce their maturation and degranulation. PLoS One (2010) 1.06
Localization of connective tissue growth factor during the period of embryo implantation in the mouse. Biol Reprod (1998) 1.03
KIT/KIT ligand in mammalian oogenesis and folliculogenesis: roles in rabbit and murine ovarian follicle activation and oocyte growth. Biol Reprod (2006) 1.01
Expression of oestrogen and progesterone receptors by mast cells alone, but not lymphocytes, macrophages or other immune cells in human upper airways. Thorax (2001) 0.92
The expression of c-kit protein in human adult and fetal tissues. Hum Reprod (1993) 0.90
Distribution and heterogeneity of mast cells in the human uterus. Hum Reprod (1997) 0.90
Generation and characterization of alpha-chymase-Cre transgenic mice. Genesis (2008) 0.88
Expression of c-kit and kit ligand at the human maternofetal interface. Cytokine (1994) 0.87
Localization of connective tissue growth factor in human uterine tissues. Mol Hum Reprod (2000) 0.86
Mast cells degranulation affects angiogenesis in the rat uterine cervix during pregnancy. Reproduction (2004) 0.84
Mast cell degranulation in rat uterine cervix during pregnancy correlates with expression of vascular endothelial growth factor mRNA and angiogenesis. Reproduction (2007) 0.84
IgE-independent mast cell activation augments contractility of nonpregnant and pregnant guinea pig myometrium. Int Arch Allergy Immunol (2008) 0.84
Mast cells reside in myometrium and cervix, but are dispensable in mice for successful pregnancy and labor. Immunol Cell Biol (2011) 0.83
Stimulation of syncytium formation in vitro in human trophoblast cells by galectin-1. Placenta (2010) 0.82
Transient reduction of placental angiogenesis in PAI-1-deficient mice. Physiol Genomics (2010) 0.81
Mast cells in the sheep, hedgehog and rat forebrain. J Anat (1999) 0.80
Mast cell mediators in airway remodeling. Chem Immunol Allergy (2005) 0.78
ANTIHISTAMINES AND THE OVUM. Br Med J (1963) 0.78
Expression of plasminogen activators in preimplantation rat embryos developed in vivo and in vitro. Reprod Biol Endocrinol (2005) 0.78
Expression of c-kit protein during placental development. Biol Reprod (1992) 0.77
Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science (1984) 33.32
Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science (1984) 32.33
The role of mononuclear phagocytes in HTLV-III/LAV infection. Science (1986) 17.33
Antibodies reactive with human T-lymphotropic retroviruses (HTLV-III) in the serum of patients with AIDS. Science (1984) 11.30
Trans-acting transcriptional regulation of human T-cell leukemia virus type III long terminal repeat. Science (1985) 6.51
Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature (2000) 5.86
Serological analysis of a subgroup of human T-lymphotropic retroviruses (HTLV-III) associated with AIDS. Science (1984) 5.43
Genomic diversity of human T-lymphotropic virus type III (HTLV-III). Science (1985) 5.33
Genomic diversity of the acquired immune deficiency syndrome virus HTLV-III: different viruses exhibit greatest divergence in their envelope genes. Proc Natl Acad Sci U S A (1985) 5.10
Isolation of human T-cell leukemia virus in acquired immune deficiency syndrome (AIDS). Science (1983) 4.72
Different requirements for EDS1 and NDR1 by disease resistance genes define at least two R gene-mediated signaling pathways in Arabidopsis. Proc Natl Acad Sci U S A (1998) 4.70
A POU-domain transcription factor in early stem cells and germ cells of the mammalian embryo. Nature (1990) 4.69
Isolation and transmission of human retrovirus (human t-cell leukemia virus). Science (1983) 4.67
Molecular cloning and characterization of the HTLV-III virus associated with AIDS. Nature (1984) 4.35
EAACI/GA(2)LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria. Allergy (2009) 4.10
EAACI/GA(2)LEN/EDF/WAO guideline: management of urticaria. Allergy (2009) 3.86
Rapid identification of methicillin-resistant Staphylococcus aureus and simultaneous species confirmation using real-time fluorescence PCR. J Clin Microbiol (2000) 3.82
Seroepidemiological studies of human T-lymphotropic retrovirus type III in acquired immunodeficiency syndrome. Lancet (1984) 3.77
CENP-C, an autoantigen in scleroderma, is a component of the human inner kinetochore plate. Cell (1992) 3.70
Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes. Cell Death Differ (2009) 3.44
Epidermal Langerhans cells--a target for HTLV-III/LAV infection. J Invest Dermatol (1987) 3.41
The eed mutation disrupts anterior mesoderm production in mice. Development (1995) 3.17
The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update. Allergy (2014) 3.10
Transformation of human umbilical cord blood T cells by human T-cell leukemia/lymphoma virus. Proc Natl Acad Sci U S A (1983) 3.01
Antibodies to HTLV-III in Swiss patients with AIDS and pre-AIDS and in groups at risk for AIDS. N Engl J Med (1985) 2.95
Structure and expression of tat-, rev-, and nef-specific transcripts of human immunodeficiency virus type 1 in infected lymphocytes and macrophages. J Virol (1990) 2.93
A comprehensive guide for the recognition and classification of distinct stages of hair follicle morphogenesis. J Invest Dermatol (1999) 2.92
Virus isolation from and identification of HTLV-III/LAV-producing cells in brain tissue from a patient with AIDS. JAMA (1986) 2.86
HTLV-III/LAV viral antigens in lymph nodes of homosexual men with persistent generalized lymphadenopathy and AIDS. Am J Pathol (1986) 2.77
The virus of Japanese adult T-cell leukaemia is a member of the human T-cell leukaemia virus group. Nature (1982) 2.75
Suramin protection of T cells in vitro against infectivity and cytopathic effect of HTLV-III. Science (1984) 2.70
Cellular localization of simian immunodeficiency virus in lymphoid tissues. I. Immunohistochemistry and electron microscopy. Am J Pathol (1989) 2.33
Regulation of IKKbeta by miR-199a affects NF-kappaB activity in ovarian cancer cells. Oncogene (2008) 2.31
T4 positive human neoplastic cell lines susceptible to and permissive for HTLV-III. Lancet (1984) 2.28
Isolation of infectious human T-cell leukemia/lymphotropic virus type III (HTLV-III) from patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related complex (ARC) and from healthy carriers: a study of risk groups and tissue sources. Proc Natl Acad Sci U S A (1985) 2.26
Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs. J Allergy Clin Immunol (2012) 2.17
Interaction of mouse polycomb-group (Pc-G) proteins Enx1 and Enx2 with Eed: indication for separate Pc-G complexes. Mol Cell Biol (1998) 2.17
Home versus hospital deliveries: follow up study of matched pairs for procedures and outcome. Zurich Study Team. BMJ (1996) 2.10
Inhibition of human immunodeficiency virus (HIV-1/HTLV-IIIBa-L) replication in fresh and cultured human peripheral blood monocytes/macrophages by azidothymidine and related 2',3'-dideoxynucleosides. J Exp Med (1988) 2.08
Monoclonal antibodies specific for p24, the major core protein of human T-cell leukemia virus type III. Proc Natl Acad Sci U S A (1985) 2.00
Prenatal stressors of human life affect fetal brain development. Dev Med Child Neurol (1994) 2.00
Risk of human immunodeficiency virus (HIV-1) infection among laboratory workers. Science (1988) 1.97
Deletion of the H19 transcription unit reveals the existence of a putative imprinting control element. Genes Dev (1997) 1.97
Functional antagonism of the Polycomb-Group genes eed and Bmi1 in hemopoietic cell proliferation. Genes Dev (1999) 1.95
Spectrum of human T-cell lymphotropic virus type III infection in children. Recognition of symptomatic, asymptomatic, and seronegative patients. JAMA (1986) 1.87
Mast cells as sentinels of innate immunity. Curr Opin Immunol (1999) 1.85
Factors responsible for differences between asymptomatic subjects and patients presenting an IgE sensitization to allergens. A GA2LEN project. Allergy (2006) 1.84
Galectins: matricellular glycan-binding proteins linking cell adhesion, migration, and survival. Cell Mol Life Sci (2007) 1.82
Complement-fixing antibody in human sera reactive with viral and soluble antigens of cytomegalovirus. J Clin Microbiol (1975) 1.81
Impaired mast cell-dependent natural immunity in complement C3-deficient mice. Nature (1997) 1.78
Isolation of HIV-1 from monocytes but not T lymphocytes. Lancet (1987) 1.77
Oncogenicity by DNA tumor viruses: enhancement after ultraviolet and cobalt-60 radiations. Science (1967) 1.71
Homology of genome of AIDS-associated virus with genomes of human T-cell leukemia viruses. Science (1984) 1.69
HTLV-III large envelope protein (gp120) suppresses PHA-induced lymphocyte blastogenesis. J Immunol (1987) 1.69
Seroprevalence of human herpesvirus-8 (HHV-8) in countries of Southeast Asia compared to the USA, the Caribbean and Africa. Br J Cancer (1999) 1.68
Infection and transformation of fresh human umbilical cord blood cells by multiple sources of human T-cell leukemia-lymphoma virus (HTLV). Int J Cancer (1983) 1.68
Safety and effectiveness of leflunomide in the treatment of patients with active rheumatoid arthritis. Results of a randomized, placebo-controlled, phase II study. Arthritis Rheum (1995) 1.67
Immunological properties of the Gag protein p24 of the acquired immunodeficiency syndrome retrovirus (human T-cell leukemia virus type III). Proc Natl Acad Sci U S A (1985) 1.67
Lymphokine production by cultured human T cells transformed by human T-cell leukemia-lymphoma virus-I. Science (1984) 1.65
EAACI/GA(2)LEN task force consensus report: the autologous serum skin test in urticaria. Allergy (2009) 1.65
Autologous whole blood injections to patients with chronic urticaria and a positive autologous serum skin test: a placebo-controlled trial. Dermatology (2006) 1.65
Karyotypic, virologic, and immunologic analyses of two continuous lymphocyte lines established from New Zealand black mice: possible relationship of chromosomal mosaicism to autoimmunity. Proc Natl Acad Sci U S A (1972) 1.65
Role of p60src kinase activity in the induction of neuroretinal cell proliferation by rous sarcoma virus. J Virol (1982) 1.64
Genetic lesions involved in temperature sensitivity of the src gene products of four Rous sarcoma virus mutants. J Virol (1986) 1.64
HLA-DR is involved in the HIV-1 binding site on cells expressing MHC class II antigens. J Immunol (1988) 1.63
Specification of axial identity in the mouse: role of the Hoxa-5 (Hox1.3) gene. Genes Dev (1993) 1.63
Molecular cloning, chromosome mapping and characterization of UBQLN3 a testis-specific gene that contains an ubiquitin-like domain. Gene (2000) 1.57
WW6: an embryonic stem cell line with an inert genetic marker that can be traced in chimeras. Proc Natl Acad Sci U S A (1995) 1.56
A quantitative description of the ground-state wave function of Cu(A) by X-ray absorption spectroscopy: comparison to plastocyanin and relevance to electron transfer. J Am Chem Soc (2001) 1.55
How to assess disease activity in patients with chronic urticaria? Allergy (2008) 1.55
EAACI/GA2LEN/EDF guideline: definition, classification and diagnosis of urticaria. Allergy (2006) 1.55
Sensitivity to inhibition by beta-chemokines correlates with biological phenotypes of primary HIV-1 isolates. Proc Natl Acad Sci U S A (1996) 1.54
Embolization of biologic glue during repair of aortic dissection. Ann Thorac Surg (1995) 1.52
The natural history of reflux and long-term effects of reflux on the kidney. J Urol (1976) 1.52
How best to fight that nasty itch - from new insights into the neuroimmunological, neuroendocrine, and neurophysiological bases of pruritus to novel therapeutic approaches. Exp Dermatol (2005) 1.51
Agriculture. Transforming U.S. agriculture. Science (2011) 1.51
Proviral DNA of a retrovirus, human T-cell leukemia virus, in two patients with AIDS. Science (1983) 1.49
Control of murine hair follicle regression (catagen) by TGF-beta1 in vivo. FASEB J (2000) 1.48
Origin of the HIV-susceptible human CD4+ cell line H9. AIDS Res Hum Retroviruses (1989) 1.45
A soluble class II cytokine receptor, IL-22RA2, is a naturally occurring IL-22 antagonist. Proc Natl Acad Sci U S A (2001) 1.43
Risk of first-generation H(1)-antihistamines: a GA(2)LEN position paper. Allergy (2010) 1.42
Expression of viral oncogenes in differentiating chick embryo neuroretinal cells infected with avian tumor viruses. Cold Spring Harb Symp Quant Biol (1980) 1.42
Pathogenesis of the slow disease of the central nervous system associated with wild mouse virus. III. Role of input virus and MCF recombinants in disease. Virology (1983) 1.42
Fatal recurrent subarachnoid hemorrhage after complete endovascular aneurysm occlusion. AJNR Am J Neuroradiol (2006) 1.40
Disease modifying and immunomodulatory effects of high dose 1 alpha (OH) D3 in rheumatoid arthritis patients. Clin Exp Rheumatol (1999) 1.39
The definition and diagnostic testing of physical and cholinergic urticarias--EAACI/GA2LEN/EDF/UNEV consensus panel recommendations. Allergy (2009) 1.39
Pathogenesis of the slow disease of the central nervous system associated with wild mouse virus. II. Role of virus and host gene products. Virology (1980) 1.39
Genetic analysis of p60v-src domains involved in the induction of different cell transformation parameters. J Virol (1986) 1.38
Schnitzler's syndrome: diagnosis, treatment, and follow-up. Allergy (2013) 1.35
Alteration of T-cell functions by infection with HTLV-I or HTLV-II. Science (1984) 1.34
Achondroplasia and hypochondroplasia. Comments on frequency, mutation rate, and radiological features in skull and spine. J Med Genet (1979) 1.34
HIV-1 and its envelope glycoprotein down-regulate chemotactic ligand receptors and chemotactic function of peripheral blood monocytes. J Immunol (1989) 1.34
Maintenance of granulocyte numbers during acute peritonitis is defective in galectin-3-null mutant mice. Immunology (1998) 1.33
NMR solution structure of a complex of calmodulin with a binding peptide of the Ca2+ pump. Biochemistry (1999) 1.33